Antineoplastic agents 470. Absolute configuration of the marine sponge bromopyrrole agelastatin A

Oncology Research

Volumn 15, Issue 1, 2005, Pages 11-20

  Pettit, George R ^a   Ducki, Sylvie ^a   Herald, Delbert L ^a   Doubek, Dennis L ^a   Schmidt, Jean M ^a   Chapuis, Jean Charles ^a  

^a ARIZONA STATE UNIVERSITY   (United States)

Author keywords

Agelastatin A; Anticancer; Hymenidin; Marine sponge

Indexed keywords

AGELASTATIN A; ANTINEOPLASTIC AGENT; BROMOPYRROLE; HYMENIDIN; PYRROLE DERIVATIVE; UNCLASSIFIED DRUG;

ANGIOGENESIS; ANIMAL CELL; ANTINEOPLASTIC ACTIVITY; ARTICLE; CANCER CELL CULTURE; CANCER INHIBITION; CONTROLLED STUDY; DRUG ISOLATION; DRUG STRUCTURE; ENDOTHELIUM CELL; HUMAN; HUMAN CELL; NONHUMAN; PRIORITY JOURNAL; SPONGE (PORIFERA); X RAY DIFFRACTION;

EID: 16344396159     PISSN: 09650407     EISSN: None     Source Type: Journal    
DOI: 10.3727/096504005775082075     Document Type: Article

References (31)

1. Pettit, G. R.; Cichacz, Z. A.; Gao, F.; Herald, C. L.; Boyd, M. R.; Schmidt, J. M.; Hooper, J. N. A. Isolation and structure of spongistatin 1. J. Org. Chem. 58:1302-1304; 1993.
2. Terauchi, T.; Terauchi, T.; Sato, I.; Tsukada, T.; Kanoh, N.; Nakata, M. Synthetic studies on altohyrtins (spongistatins): Synthesis of the C15-C28 (CD) spiroacetal portion. Tetrahedron Lett. 41:2649-2653; 2000.
3. 5, subunit of spongistatin 1 (Altohyrtin A) starting from (R)-3-benzyloxy-2-methylpropan-1-ol. J. Org. Chem. 65:3346-3356; 2000.
4. Evans, D. A.; Trotter, B. W.; Coleman, P. J.; Côté, B.; Dias, L. C.; Rajapakse, H. A.; Tyler, A. N. Enantioselective total synthesis of altohyrtin C (spongistatin 2). Tetrahedron 55:8671-8726; 1999.
5. Pettit, G. R.; Tan, R.; Gao, F.; Williams, M. D.; Doubek, D. L.; Boyd, M. R.; Schmidt, J. M.; Chapuis, J.-C.; Hamel, E.; Bai, R.; Hooper, J. N. A.; Tackett, L. P. Isolation and structure of halistatin 1 from the Eastern Indian Ocean marine sponge Phakellia carteri. J. Org. Chem. 58:2538-2543; 1993.
6. Pettit, G. R.; Gao, F.; Doubek, D. L.; Boyd, M. R.; Hamel, E.; Bai, R. L.; Schmidt, J. M.; Tackett, L. P.; Rutzler, K. Antineoplastic agents. 252. Isolation of halistatin 2 from the Comoros marine sponge Axinella carteri. Gazz. Chim. Ital. 123:371-377; 1993.
7. Uemoto, H.; Tsuda, M.; Kobayashi, J. Mukanadins A-C, new bromopyrrole alkaloids from marine sponge Agelas nakamurai. J. Nat. Prod. 62:1581-1583; 1999.
8. Assmann, M.; Lichte, E.; van Soest, R. W. M.; Köck, M. New bromopyrrole alkaloid from the marine sponge Agelas wiedenmayeri. Org. Lett. 1:455-457; 1999.
9. Eder, C.; Proksch, P.; Wray, V.; van Soest, R. W. M.; Ferdinandus, E.; Pattisina, L. A.; Sudarsono, New bromopyrrole alkaloids from the Indopacific sponge Agelas nakamurai. J. Nat. Prod. 62:1295-1297; 1999.
10. Iwagawa, T.; Kaneko, M.; Okamura, H.; Nakatani, M.; van Soest, R. W. M. New alkaloids from the Papua New Guinean sponge Agelas nakamurai. J. Nat. Prod. 61: 1310-1312; 1998.
11. Koenig, G. M.; Wright, A. D.; Linden, A. Antiplasmodial and cytotoxic metabolites from Maltese sponge Agelas oroides. Planta Med. 64:443-447; 1998.
12. Faulkner, D. J. Marine natural products. Nat. Prod. Rep. 12:223-269; 1995.
13. Pettit, G. R.; Hogan-Pierson, F.; Herald, C. L. Anticancer drugs from animals, plants and microorganisms. New York: John Wiley-Interscience; 1994.
14. Kobayashi, J.; Ohizumi, Y.; Nakamura, H.; Hirata, Y. A novel antagonist of serotonergic receptors, hymenidin, isolated from the Okinawan marine sponge Hymeniacidon species. Experientia 42:1176-1177; 1986.
15. D'Ambrosio, M.; Guerriero, A.; Debitus, C.; Ribes, O.; Pusset, J.; Leroy, S.; Pietra, F. Agelastatin A, a new skeleton cytotoxic alkaloid of the oroidin family. Isolation from the axinellid sponge Agelas demdromorpha of the Coral Sea. J. Chem. Soc. Chem. Commun. (16):1305-1306; 1993.
16. Hong, T. W.; Jimenez, D. R.; Molinski, T. F. Agelastatins C and D, new pentacyclic bromopyrroles from the sponge Cymbastela sp., and potent arthropod toxicity of (-)-agelastatin A. J. Nat. Prod. 61:158-161; 1998.
17. Taraboletti, G.; Giavazzi, R. Modelling approaches for angiogenesis. Eur. J. Cancer 40:881-889; 2004.
18. Daly, M. E.; Makris, A.; Reed, M.; Lewis, C. E. Hemostatic regulators of tumor angiogenesis: A source of anti-angiogenic agents for cancer treatment? J. Natl. Cancer Inst. 95:1660-1673; 2003.
19. D'Ambrosio, M.; Guerriero, A.; Chiasera, G.; Pietra, F. Conformational preferences and absolute configuration of agelastatin A, a cytotoxic alkaloid of the axinellid sponge Agelas dendromorpha from the Coral Sea, via combined molecular modeling, NMR, and exciton splitting for diamide and hydroxyamide derivatives. Helv. Chim. Acta 77: 1895-1902; 1994.
20. D'Ambrosio, M.; Guerriero, A.; Ripamonti, M.; Debitus, C.; Waikedre, J.; Pietra, F. The active centers of agelastatin A, a strongly cytotoxic alkaloid of the Coral Sea axinellid sponge Agelas dendromorpha, as determined by comparative bioassays with semisynthetic derivatives. Helv. Chim. Acta 79:727-735; 1996.
21. Stien, D.; Anderson, G. T.; Chase, C. E.; Koh, Y-H.; Weinreb, S. M. Total synthesis of the antitumor marine sponge alkaloid agelastatin A. J. Am. Chem. Soc. 121: 9574-9579; 1999.
22. Anderson, G. T.; Chase, C. E.; Koh, Y-H.; Stien, D.; Weinreb, S. M.; Shang, M. Studies on total synthesis of the cytotoxic marine alkaloid agelastatin A. J. Org. Chem. 63:7594-7595; 1998.
23. Anderson, G. T. An antibody catalyzed ester hydrolysis and a synthetic approach towards agelastatin A. Diss. Abstr. Int. B 56:6741; 1996.
24. Hale, K. J.; Domostoj, M. M.; Tocher, D. A.; Irving, E.; Scheinmann, F. Enantiospecific formal total synthesis of the tumor and GSK-3 inhibiting alkaloid, (-)-agelastatin A. Org. Lett. 5:2927-2930; 2003.
25. Monks, A.; Scudiero, D.; Skehan, P.; Shoemaker, R.; Paull, K.; Vistica, D.; Hose, C.; Langley, J.; Cronise, P.; Vaigro-Wolff, A. J. Natl. Cancer Inst. 83:757-766; 1991.
26. Suffness, M.; Douros, J. Methods Cancer Res. XVI:73-126; 1979.
27. Developmental Therapeutic Program NCI/NIH, Discovery Services, Angiogenesis Resource Center (http://dtp.nci. nih.gov/aa-resources/aa_index. html)
28. SHELXTL-Version 5.1 (1997). An integrated suite of programs for the determination of crystal structures from diffraction data, is available from Brüker XS, Inc., Madison, Wisconsin 53719, USA. This package includes, among others, XPREP (an automatic space group determination program), SHELXS (a structure solution program via Patterson or direct methods), and SHELXL (structure refinement software).
29. North, A. C. T.; Phillips, D. C.; Mathews, F. S. A semi-empirical method of absorption correction. Acta Crystallogr. Sect. A 24:351-359; 1968.
30. Crystallographic data for agelastatin A (2) have been deposited with the Cambridge Data Centre. Copies of the data can be obtained free of charge, on application to the Director, CCDC, 12 Union Road, Cambridge, CB2 IEZ, UK (fax: +44-(0)-1223-336033 or E-mail: deposit@ccdc. cam.ac.uk).
31. Flack, H. D. On enantiomorph-polarity estimation. Acta Crystallogr. Sect. A A39:876-881; 1983.